Publications by authors named "Jacky Crequit"

Claim this Profile
C
Combined, patient-level, analysis of two randomised trials evaluating the addition of denosumab to standard first-line chemotherapy in advanced NSCLC - The ETOP/EORTC SPLENDOUR and AMGEN-249 trials.
Solange Peters, Sarah Danson, Dunson Ejedepang, Urania Dafni, Baktiar Hasan, Jacky Crequit

Lung Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial.
Nathalie Baize, Isabelle Monnet, Laurent Greillier, Margaux Geier, Hervé Lena, Jacky Crequit

Lancet Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential Antiangiogenic Treatment Eligibility of Patients with Squamous Non-Small-Cell Lung Cancer: EPISQUAMAB Study (GFPC 2015-01).
Alain Vergnenègre, Victor Basse, Gwenaelle Le Garff, Olivier Bylicki, Catherine Dubos-Arvis, Jacky Crequit

Cancer Manag Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early mortality in lung cancer: French prospective multicentre observational study.
Michel Grivaux, Didier Debieuvre, Dominique Herman, Christine Lemonnier, Jean-Michel Marcos, Jacky Crequit

BMC Pulm Med· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized trial comparing adjuvant chemotherapy with gemcitabine plus cisplatin with docetaxel plus cisplatin in patients with completely resected non-small-cell lung cancer with quality of life as the primary objective.
Fabrice Barlesi, Christos Chouaid, Jacky Crequit, Hervé Le Caer, Jean-Louis Pujol

Interact Cardiovasc Thorac Surg· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-utility analysis of maintenance therapy with gemcitabine or erlotinib vs observation with predefined second-line treatment after cisplatin-gemcitabine induction chemotherapy for advanced NSCLC: IFCT-GFPC 0502-Eco phase III study.
Isabelle Borget, Maurice Pérol, David Pérol, Armelle Lavolé, Laurent Greillier, Jacky Crequit

BMC Cancer· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer.
Delphine Lerouge, Alain Rivière, Eric Dansin, Christos Chouaid, Cécile Dujon, Jacky Crequit

BMC Cancer· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of pemetrexed as second-line therapy in advanced NSCLC after either treatment-free interval or maintenance therapy with gemcitabine or erlotinib in IFCT-GFPC 05-02 phase III study.
Olivier Bylicki, Céline Ferlay, Christos Chouaid, Armelle Lavolé, Fabrice Barlési

J Thorac Oncol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, phase III study of gemcitabine or erlotinib maintenance therapy versus observation, with predefined second-line treatment, after cisplatin-gemcitabine induction chemotherapy in advanced non-small-cell lung cancer.
Maurice Pérol, Christos Chouaid, David Pérol, Fabrice Barlési, Radj Gervais, Jacky Crequit

J Clin Oncol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of second-line chemotherapy for non-small cell lung cancer: an economic, randomized, prospective, multicenter phase III trial comparing docetaxel and pemetrexed: the GFPC 05-06 study.
Alain Vergnenegre, Romain Corre, Henri Berard, Dominique Paillotin, Cecile Dujon, Jacky Crequit

J Thorac Oncol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open multicenter phase II trial of weekly docetaxel for advanced-stage non-small-cell lung cancer in elderly patients with significant comorbidity and/or poor performance status: The GFPC 02-02b study.
Hervé LeCaer, Fabrice Barlesi, Gilles Robinet, Pierre Fournel, Laurence Geriniere, Jacky Crequit

Lung Cancer· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Radio-chemotherapy combinations in non operable localized non small cell lung carcinoma: updates and perspectives].
Ali Hasbini, Fabienne Ozanne, Hanifa Ammarguellat, Jacky Crequit, Thierry Dolige

Bull Cancer· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis